Lanxiang Wu

1.3k total citations
41 papers, 918 citations indexed

About

Lanxiang Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lanxiang Wu has authored 41 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Lanxiang Wu's work include Drug Transport and Resistance Mechanisms (10 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (8 papers). Lanxiang Wu is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (8 papers). Lanxiang Wu collaborates with scholars based in China, Netherlands and India. Lanxiang Wu's co-authors include Chunjie Wen, Hong‐Hao Zhou, Hong‐Hao Zhou, Lijuan Fu, Ge Xu, Hecun Zou, Jiafeng Huang, Shuai He, Xia Qin and Yi Dai and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lanxiang Wu

41 papers receiving 913 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lanxiang Wu China 19 505 278 146 88 80 41 918
Ayşegül Varol Germany 4 491 1.0× 162 0.6× 114 0.8× 69 0.8× 65 0.8× 7 910
Xiaoran Yin China 16 428 0.8× 208 0.7× 95 0.7× 72 0.8× 39 0.5× 28 854
Felicia Fei‐Lei Chung Malaysia 21 737 1.5× 205 0.7× 327 2.2× 60 0.7× 53 0.7× 44 1.3k
Lakshmipathi Khandrika United States 10 719 1.4× 301 1.1× 190 1.3× 68 0.8× 75 0.9× 19 1.4k
Yu Meng China 15 491 1.0× 153 0.6× 181 1.2× 39 0.4× 46 0.6× 29 825
Tianxin Yang China 21 671 1.3× 120 0.4× 170 1.2× 170 1.9× 62 0.8× 30 1.2k
Maochao Luo China 15 552 1.1× 238 0.9× 155 1.1× 54 0.6× 33 0.4× 20 922
Mengmeng Wang China 17 507 1.0× 130 0.5× 99 0.7× 32 0.4× 42 0.5× 51 952
Simon Wing Fai Mok Macao 21 598 1.2× 92 0.3× 205 1.4× 60 0.7× 88 1.1× 35 1.0k

Countries citing papers authored by Lanxiang Wu

Since Specialization
Citations

This map shows the geographic impact of Lanxiang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanxiang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanxiang Wu more than expected).

Fields of papers citing papers by Lanxiang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanxiang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanxiang Wu. The network helps show where Lanxiang Wu may publish in the future.

Co-authorship network of co-authors of Lanxiang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lanxiang Wu. A scholar is included among the top collaborators of Lanxiang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanxiang Wu. Lanxiang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaoqing, Lingling Li, Qilin Zhao, et al.. (2024). Utility of patient-derived xenografts to evaluate drug sensitivity and select optimal treatments for individual non-small-cell lung cancer patients. Molecular Medicine. 30(1). 209–209. 2 indexed citations
2.
Zhou, Xinyuan, Yanxia Qin, Jiangxue Li, et al.. (2024). LncPepAtlas: a comprehensive resource for exploring the translational landscape of long non-coding RNAs. Nucleic Acids Research. 53(D1). D468–D476. 3 indexed citations
3.
Xia, Weifeng, Wenyi Liu, Chunjie Wen, et al.. (2024). Romidepsin exhibits anti-esophageal squamous cell carcinoma activity through the DDIT4-mTORC1 pathway. Cancer Gene Therapy. 31(5). 778–789. 1 indexed citations
4.
Wang, Nan, et al.. (2022). Lnc-TMEM132D-AS1 as a potential therapeutic target for acquired resistance to osimertinib in non-small-cell lung cancer. Molecular Omics. 19(3). 238–251. 15 indexed citations
5.
6.
Ma, Peng, Huaiyong Zhang, Bin Li, et al.. (2021). Identification and characterization of circRNAs in maize seedlings under deficient nitrogen. Plant Biology. 23(5). 850–860. 15 indexed citations
7.
Wen, Chunjie, et al.. (2020). Genome-wide identification and characterization of long non-coding RNAs involved in acquired resistance to gefitinib in non-small-cell lung cancer. Computational Biology and Chemistry. 87. 107288–107288. 5 indexed citations
8.
Wen, Chunjie, Ge Xu, Shuai He, et al.. (2020). Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines. Journal of Cancer. 11(13). 3816–3826. 21 indexed citations
9.
Guo, Xiaoyu, et al.. (2019). Identification of miRNA signature associated with BMP2 and chemosensitivity of TMZ in glioblastoma stem-like cells. Genes & Diseases. 7(3). 424–439. 17 indexed citations
10.
Chen, Jin, et al.. (2019). MicroRNA-26a-2 maintains stress resiliency and antidepressant efficacy by targeting the serotonergic autoreceptor HTR1A. Biochemical and Biophysical Research Communications. 511(2). 440–446. 32 indexed citations
11.
Wu, Jing, Xuan Feng, Yan Du, et al.. (2019). β-catenin/LIN28B promotes the proliferation of human choriocarcinoma cells via Let-7a repression. Acta Biochimica et Biophysica Sinica. 51(5). 455–462. 6 indexed citations
12.
Huang, Jiafeng, Chunjie Wen, Guozhi Zhao, et al.. (2018). Overexpression of ABCB4 contributes to acquired doxorubicin resistance in breast cancer cells in vitro. Cancer Chemotherapy and Pharmacology. 82(2). 199–210. 37 indexed citations
13.
Zhao, Hongbo, et al.. (2018). ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC. Frontiers in Pharmacology. 9. 1312–1312. 37 indexed citations
14.
Wen, Chunjie, Lanxiang Wu, Lijuan Fu, Bing Wang, & Hong‐Hao Zhou. (2017). Unifying mechanism in the initiation of breast cancer by metabolism of estrogen. Molecular Medicine Reports. 16(2). 1001–1006. 21 indexed citations
15.
Zhang, Jun, Xia Qin, Bin Wang, et al.. (2017). Zinc oxide nanoparticles harness autophagy to induce cell death in lung epithelial cells. Cell Death and Disease. 8(7). e2954–e2954. 165 indexed citations
16.
Wen, Chunjie, Lanxiang Wu, Lijuan Fu, Xue Zhang, & Hong‐Hao Zhou. (2016). Berberine enhances the anti-tumor activity of tamoxifen in drug-sensitive MCF-7 and drug-resistant MCF-7/TAM cells. Molecular Medicine Reports. 14(3). 2250–2256. 39 indexed citations
17.
Wu, Lanxiang, Hongbo Zhao, Chunjie Wen, et al.. (2016). Combined Influence of Genetic Polymorphism and DNA Methylation on ABCB1 Expression and Function in Healthy Chinese Males. European Journal of Drug Metabolism and Pharmacokinetics. 42(4). 627–634. 7 indexed citations
18.
Wen, Chunjie, Lanxiang Wu, Lijuan Fu, et al.. (2014). Preferential Induction of CYP1A1 over CYP1B1 in Human Breast Cancer MCF-7 Cells after Exposure to Berberine. Asian Pacific Journal of Cancer Prevention. 15(1). 495–499. 14 indexed citations
19.
Pang, Yunwei, et al.. (2014). Cloning and sequence analysis of the Blumea balsamifera DC farnesyl diphosphate synthase gene. Genetics and Molecular Research. 13(4). 9874–9882. 2 indexed citations
20.
Wu, Lanxiang, Chengxian Guo, Jing Yu, et al.. (2011). Inhibition of the organic anion‐transporting polypeptide 1B1 by quercetin: anin vitroandin vivoassessment. British Journal of Clinical Pharmacology. 73(5). 750–757. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşegül Varol Breakdown of academic impact, for papers by Xiaoran Yin Breakdown of academic impact, for papers by Felicia Fei‐Lei Chung Breakdown of academic impact, for papers by Lakshmipathi Khandrika Breakdown of academic impact, for papers by Yu Meng Breakdown of academic impact, for papers by Tianxin Yang Breakdown of academic impact, for papers by Maochao Luo Breakdown of academic impact, for papers by Mengmeng Wang Breakdown of academic impact, for papers by Simon Wing Fai Mok
Rankless by CCL
2026